Penczek Ronald W sold $149K of ELV
Penczek Ronald W (CAO & Controller) sold 369 shares of Elevance Health, Inc. (ELV) at $403.16 ($0.15M total) on 2026-06-12.
How this was made
The 30-second read
Why it matters
This provides a fresh datapoint on insider behavior but does not include any operational, financial, or regulatory development for Elevance Health.
Market read
Traders may note insider selling, but the disclosure lacks a fundamental catalyst and is unlikely to drive sustained repricing on its own.
What to watch
Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without additional filings or context, signal quality is limited.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for Elevance Health, Inc.
Ticker impact
SEC Form 4 shows Elevance Health CAO & Controller Penczek sold 369 shares in an open-market transaction on 2026-06-12.
Low near-term impact; any reaction is likely muted unless part of a larger pattern.
The filing is a Form 4 insider transaction with no stated earnings, guidance, or regulatory catalyst; it also notes no 10b5-1 plan, but the disclosed size is modest (about $149k).
Market effects
Minimal; single-company insider sale does not reset sector expectations.
None indicated.
None indicated.
Counterpoint
Absence of a 10b5-1 plan could be interpreted as less “scheduled” selling, but the transaction size is small and not tied to any new company event.
Key entities
- issuerElevance Health, Inc.
Subject of the SEC Form 4 insider transaction disclosure.
- insiderRonald W. Penczek
CAO & Controller who sold 369 shares in an open-market sale.
%252FElevance%252520Health%252520world%252520headquarters%252520By%252520jetcityimage.jpeg&w=3840&q=75)
